Prominent Drug Delivery Devices Market Trend for 2025: Connectivity In Drug Delivery Devices That Is Innovative Focusing On Autoinjectors To Improve The Patient Experience

How Are the key drivers contributing to the expansion of the drug delivery devices market?
The escalating occurrence of chronic ailments like cardiovascular diseases, diabetes, cancer, and others is anticipated to fuel the growth of the drug delivery devices market. For example, data from the National Library of Medicine, a medical library run by the US federal government, predicted in January 2023 that the segment of US individuals aged 50 or above with at least one chronic condition would surge by 99.5%. This escalation would lift the figure from 71.522 million in 2020 to 142.66 million by 2050. There are numerous drug administration routes for medicinal drugs. The invention of novel drug delivery systems is crucial in the pharmaceutical sector. Due to the escalating occurrence of these conditions, global investment in drug delivery research and development (R&D) is on the rise. The majority of pharma firms are concentrating on various drug delivery technologies to deliver exceptional benefits and improved results for their available products. Therefore, the escalating occurrence of chronic diseases is leading to a heightened use of therapeutic drugs and therapies. This factor is anticipated to serve as a catalyst for the expansion of the drug delivery devices market.

Get Your Drug Delivery Devices Market Report Here:
https://www.thebusinessresearchcompany.com/report/drug-delivery-devices-global-market-report

What growth opportunities are expected to drive the drug delivery devices market's CAGR through 2034?
In the past few years, the drug delivery devices market has experienced a significant expansion. It is projected to increase from $91.03 billion in 2024 to $96.73 billion in 2025 with a compound annual growth rate (CAGR) of 6.3%. The remarkable expansion during the historical period is a result of the fast growth in the elderly population, expansion in healthcare facilities, economic strides in emerging markets, and amplified healthcare spending.

In the coming years, the drug delivery devices market is projected to experience robust growth. It is anticipated to reach $124.82 billion by 2029, with a compound annual growth rate (CAGR) of 6.6%. This expansion during the projected period can be attributed to a rise in chronic diseases, an increased demand for injectables, a growing need for drug delivery devices, and the sudden emergence of severe infections. Key trends during this period are anticipated to include investment in microneedle drug technology, self-injectable drug delivery device development, a focus on mergers and acquisitions, and an increase in investment in wearable drug delivery devices.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2833&type=smp

What are the emerging trends shaping the future of the drug delivery devices market?
To gain a competitive advantage in the drug delivery device sector, key players are concentrating their efforts on creating unique devices such as autoinjectors that come equipped with built-in connectivity. Autoinjectors are specially designed medical tools for self-administering precise amounts of medication. To illustrate, in May 2022, Jabil Healthcare, a healthcare manufacturing solutions company based in the US, unveiled the Qfinity autoinjector platform, a reusable medical device for drug delivery. The Qfinity autoinjector platform is distinguished by its simplicity, reusability, and modularity as a solution for subcutaneous self-administration of drugs, offering an economically viable choice to rival market offerings while encouraging environmentally-friendly drug delivery within the pharmaceutical sector. Its flexible design accommodates a range of drug volumes and viscosities and features a patient-focused design that delivers up to 65% lower cost per injection compared to high-ranking single-use autoinjectors. The robust Qfinity device can handle over 100 injections and works with 1mL or 2.25mL pre-filled disposable cassettes. Moreover, its minimized use of components and materials results in an approximate 65% reduction in cost per injection, a 60% reduction in carbon emissions, a 50% decrease in manufacturing space, and a 70% drop in capital expenditure (CAPEX).

Which growth-oriented segments of the drug delivery devices market are leading the industry's development?
The drug delivery devices market covered in this report is segmented -

1) By Route Of Administration: Oral Drug Delivery, Injectable Drug Delivery, Topical Drug Delivery, Ocular Drug Delivery, Pulmonary Drug Delivery, Nasal Drug Delivery, Transmucosal Drug Delivery, Implantable Drug Delivery
2) By Patient Care Setting: Hospitals, Diagnostic Centers, Ambulatory Surgery Centers/Clinics, Home Care Settings, Other Patient Care Settings
3) By Application: Cancer, Infectious Diseases, Respiratory Diseases, Diabetes, Cardiovascular Diseases, Autoimmune Diseases, Central Nervous System Disorders, Other Applications

Subsegments:
1) By Oral Drug Delivery: Tablets and Capsules, Oral Sprays, Oral Liquids, Oral Disintegrating Tablets
2) By Injectable Drug Delivery: Syringes (manual and auto-disable), Vials and Cartridges, Pen Injectors, Infusion Pumps
3) By Topical Drug Delivery: Creams and Ointments, Transdermal Patches, Gels and Lotions, Powders
4) By Ocular Drug Delivery: Eye Drops, Ocular Inserts, Contact Lens Drug Delivery Systems
5) By Pulmonary Drug Delivery: Metered-Dose Inhalers (MDIs), Dry Powder Inhalers (DPIs), Nebulizers
6) By Nasal Drug Delivery: Nasal Sprays, Nasal Powders, Nasal Drops
7) By Transmucosal Drug Delivery: Buccal Tablets, Sublingual Tablets, Mucoadhesive Films
8) By Implantable Drug Delivery: Drug-Implantable Devices, Biodegradable Implants, Reservoir-based Implants

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2833

What regions are leading the charge in the drug delivery devices market?
North America was the largest region in the drug delivery devices market in 2024. Asia-Pacific was the second-largest region in the global drug delivery devices market. The regions covered in the drug delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

What companies are at the forefront of innovation in the drug delivery devices market?
Major companies operating in the drug delivery devices market include Becton, Dickinson and Company, Baxter International, B. Braun Melsungen AG, Catalent, 3M Company, West Pharmaceutical Services, Inc., Gerresheimer AG, Smiths Medical, Boehringer Ingelheim, SMC Ltd., Elcam Medical, Eli Lilly and Company, Injex, Novartis AG, Novo Nordisk A/S, Pfizer Inc, Sanofi Sa, Schott AG, Terumo Corporation, Teva Pharmaceuticals, Ypsomed Holding AG, F. Hoffmann-La Roche AG, GlaxoSmithKline, AstraZeneca, Congenica Ltd., UCB, Alkermes, Aptalis Pharma, Inc., Johnson & Johnson, Nektar Therapeutics, SkyePharma PLC, Pharmasyntez, NEARMEDIC PLUS LLC, Copernicus, Medtronic, Philips, Siemens, Stryker, GE Healthcare, Teleflex Medical, Gilero, Kedalion Therapeutics, MediPrint Ophthalmics, Nemera, Pendant Biosciences, Battelle Medical Devices, Merck & Co. Inc., Antares Pharma, Abbot, Allergan, Bilim Pharmaceuticals, H&T Presspart, Hovione Technology, Sorrel Medical, Syqe Medical, Julphar, ResMed Inc, Covidien plc

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=2833&type=smp

What Is Covered In The Drug Delivery Devices Global Market Report?

• Market Size Forecast: Examine the drug delivery devices market size across key regions, countries, product categories, and applications.
• Segmentation Insights: Identify and classify subsegments within the drug delivery devices market for a structured understanding.
• Key Players Overview: Analyze major players in the drug delivery devices market, including their market value, share, and competitive positioning.
• Growth Trends Exploration: Assess individual growth patterns and future opportunities in the drug delivery devices market.
• Segment Contributions: Evaluate how different segments drive overall growth in the drug delivery devices market.
• Growth Factors: Highlight key drivers and opportunities influencing the expansion of the drug delivery devices market.
• Industry Challenges: Identify potential risks and obstacles affecting the drug delivery devices market.
• Competitive Landscape: Review strategic developments in the drug delivery devices market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.